Citation Impact
1 by Nobel laureates 3 from Science/Nature 72 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of Steven Blotner being referenced
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors
2021
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
2019 Standout
Author Peers
| Author | Oncology | Infectious Diseases | Molecular Biology | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Steven Blotner | 585 | 46 | 253 | 221 | 36 | 1.1k | |
| Marion Blute | 17 | 31 | 985 | ||||
| Chester R. Lapeza | 17 | 38 | 7 | 25 | 1.2k | ||
| Peter Handke | 63 | 108 | |||||
| Qin Liu | 59 | 1 | 209 | 15 | 11 | 268 | |
| A. Jamali | 5 | 7 | 14 | 564 |
All Works
Loading papers...